Curve Therapeutics

Southampton, United Kingdom Founded: 2019 • Age: 7 yrs
Protein degradation therapeutics are developed for drug discovery.

About Curve Therapeutics

Curve Therapeutics is a company based in Southampton (United Kingdom) founded in 2019.. Curve Therapeutics has raised $46.75 million across 2 funding rounds from investors including Pfizer, British Patient Capital and Columbus Venture Partners. Curve Therapeutics offers products and services including Microcycle Platform and Pipeline Drugs.

  • Headquarter Southampton, United Kingdom
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Curve Therapeutics Limited
Operational Areas
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $46.75 M (USD)

    in 2 rounds

  • Latest Funding Round
    $43.89 M (USD), Series A

    Feb 27, 2024

  • Investors
    Pfizer

    & 4 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Curve Therapeutics

Curve Therapeutics offers a comprehensive portfolio of products and services, including Microcycle Platform and Pipeline Drugs. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

A gene-encoded platform is used for unlocking therapeutic potential of intracellular targets by discovering cyclic peptides and small molecules

Cyclic peptide and small molecule drugs are developed to address high-priority intracellular disease targets in cancer and immunology

People of Curve Therapeutics
Headcount 10-50
Employee Profiles 8
Employee Profiles
People
Ali Tavassoli
Chief Scientific Officer
People
Rich Rathmell
Vice President Of Chemisty
People
Leonardo Baldassarre
Senior Scientist & Team Leader
People
Simon Kerry
Chief Executive Officer

Unlock access to complete

Funding Insights of Curve Therapeutics

Curve Therapeutics has successfully raised a total of $46.75M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $43.89 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Series A — $43.9M
  • First Round

    (27 Jun 2019)

  • Investors Count 5
Date Amount Transaction Name Valuation Lead Investors Investors
Feb, 2024 Amount Series A - Curve Therapeutics Valuation British Patient Capital , Pfizer
Jun, 2019 Amount Seed - Curve Therapeutics Valuation Advent Life Sciences , Epidarex Capital
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Curve Therapeutics

Curve Therapeutics has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Pfizer, British Patient Capital and Columbus Venture Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Venture capital co-investments are made in UK later-stage businesses.
Founded Year Domain Location
Columbus Venture Partners is focused on biotechnology investment funds.
Founded Year Domain Location
Early and mid-stage life science focused VC firm investing in the US and Europe
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Curve Therapeutics

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Curve Therapeutics

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Curve Therapeutics Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Curve Therapeutics

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Curve Therapeutics

Frequently Asked Questions about Curve Therapeutics

When was Curve Therapeutics founded?

Curve Therapeutics was founded in 2019.

Where is Curve Therapeutics located?

Curve Therapeutics is headquartered in Southampton, United Kingdom.

Is Curve Therapeutics a funded company?

Curve Therapeutics is a funded company, having raised a total of $46.75M across 2 funding rounds to date. The company's 1st funding round was a Seed of $2.85M, raised on Jun 27, 2019.

What does Curve Therapeutics do?

Curve Therapeutics was founded in 2019 and is based in Southampton, United Kingdom. Operations are centered in the biotechnology sector, where novel drug candidates are advanced using proprietary platforms for targeted protein degradation. Focus is placed on extracellular protein modulation to address unmet medical needs. Research and development activities span early discovery through preclinical stages, with an emphasis on oncology and other therapeutic areas.

What products or services does Curve Therapeutics offer?

Curve Therapeutics offers Microcycle Platform and Pipeline Drugs.

Who are Curve Therapeutics's investors?

Curve Therapeutics has 5 investors. Key investors include Pfizer, British Patient Capital, Columbus Venture Partners, Advent Life Sciences, and Epidarex Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available